Visual Acuity

In this Healio Video Perspective from the Vit-Buckle Society annual meeting, Sally S. Ong, MD, discusses a study that investigated potential predictors for worse visual acuity at 1 year after rhegmatogenous retinal detachment repair.

WASHINGTON — In this Healio video, Jeffry Gerson, OD, FAAO, shares results from the LIGHTSITE III clinical trial, which evaluated photobiomodulation treatment in patients with dry age-related macular degeneration.

SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Daniel H. Chang, MD, speaks about the Tecnis Symfony OptiBlue extended depth of focus IOL powered by InteliLight technology from Johnson & Johnson Vision.

OCS-01 eye drops met the primary and secondary endpoints for the treatment of diabetic macular edema in stage 1 of the phase 3 DIAMOND trial, according to a press release from Oculis.

SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, George O. Waring IV, MD, FACS, discusses the first-in-human results of the OmniVu IOL system from Atia Vision.

NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, David M. Brown, MD, discusses clinical characteristics of patients in the phase 2/3 PHOTON trial.

Ophthalmologists can usually examine the cornea, lens and vitreous with the slit lamp to learn if there is sufficient clarity to allow good vision.

VILAMOURA, Portugal — Phakic IOL explantation is a safe procedure that can lead to good functional outcomes, provided patients have been followed up regularly with one visit per year to measure endothelial cell count, according to a study.

Researchers have developed a step-by-step calculation procedure to determine the appropriate digital reading display for individuals with low vision, according to a study published in Optometry and Vision Science.

An analysis of real-world data showed that Tepezza helped improve visual acuity in patients with dysthyroid optic neuropathy, according to a press release.